List of insiders holdings for VIVUS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| NORTH TIDE CAPITAL LLC North Tide Capital Master LP Laughlin Conan 10% Owner | 2017-06-06 17:06:08 | 5,000,000 0 | 5,000,000 | Form 13G |
| Bass Rolf E. SEE REMARKS 10% Owner | 2013-06-07 10:38:39 | 9500 4,393,316 | 4,402,816 | Form 3 |
| Colin Samuel F Director 10% Owner | 2014-05-01 17:10:02 | 500,000 2,748,800 | 3,248,800 | Form 4 |
| DENNER ALEXANDER J Sarissa Capital Management LP Sarissa Capital Offshore Master Fund LP Sarissa Capital Domestic Fund LP See Footnotes Below | 2013-07-23 21:52:26 | 0 2,007,099 | 2,007,099 | Form 4 |
| Zook Anthony P. Chief Executive Officer | 2013-07-29 21:15:27 | 1,000,000 0 | 1,000,000 | Form 4 |
| Fischer Seth H. Z. Consultant | 2018-01-03 19:11:29 | 633,978 0 | 633,978 | Form 4 |
| WILSON LELAND F Chief Executive Officer | 2013-01-29 21:28:54 | 319,925 0 | 319,925 | Form 4 |
| WALLISER RICHARD W CFO | 2004-02-13 10:54:01 | 190,715 0 | 190,715 | Form 5 |
| TAM PETER Y President | 2013-01-29 21:28:10 | 178,076 0 | 178,076 | Form 4 |
| Sris Mayu Resigned as Director 1/16/2017 | 2017-01-18 16:05:38 | 142,364 0 | 142,364 | Form 4 |
| Amos John P. Chief Executive Officer | 2020-01-31 17:25:29 | 137,500 0 | 137,500 | Form 4 |
| Sanford Svai S Chief Financial Officer | 2015-08-05 21:06:23 | 128,359 0 | 128,359 | Form 4 |
| MORRIS TIMOTHY E VP, Finance and CFO | 2013-09-09 19:29:29 | 116,007 0 | 116,007 | Form 4 |
| Mohamed Johann Noor Interim CFO & Interim CAO | 2015-10-05 16:33:50 | 110,444 0 | 110,444 | Form 3 |
| MILLER MICHAEL PATRICK Chief Commercial Officer | 2013-01-29 21:00:45 | 98,055 0 | 98,055 | Form 4 |
| MILLER MICHAEL Chief Commercial Officer | 2012-01-31 14:19:47 | 95,755 0 | 95,755 | Form 4 |
| Suh Kenneth President | 2019-01-25 19:56:08 | 85,000 0 | 85,000 | Form 4 |
| MARIO ERNEST Director | 2013-05-30 13:54:47 | 81,125 0 | 81,125 | Form 4 |
| Perry Lee VP & Chief Accounting Officer | 2013-01-29 21:01:41 | 70,000 0 | 70,000 | Form 4 |
| Day Wesley VP, Clinical Development | 2016-04-20 16:44:22 | 46,569 0 | 46,569 | Form 4/A |
| FIRST MANHATTAN CO First BioMed Management Associates LLC ROSENMAN HERM BIRO JON C Norton David Y KEATING MELVIN L SEE REMARKS 10% Owner | 2016-02-12 09:49:38 | 45,470 0 | 45,470 | Form 13G |
| Forrest Lori VP, Operations & General Mgr. | 2005-01-26 15:21:27 | 35,000 0 | 35,000 | Form 4 |
| Varghese Santosh T Chief Medical Officer | 2020-01-31 17:23:55 | 32,000 0 | 32,000 | Form 4 |
| Slebir John L SVP, Business Development & GC | 2020-01-31 17:24:36 | 32,000 0 | 32,000 | Form 4 |
| Oki Mark K Chief Financial Officer & CAO | 2020-01-31 17:25:05 | 32,000 0 | 32,000 | Form 4 |
| Oehrlein M. Scott Chief Operations Officer | 2019-01-25 20:00:15 | 31,000 0 | 31,000 | Form 4 |
| MARSH GUY P VP, US Operations & GM | 2016-04-20 16:58:20 | 30,854 0 | 30,854 | Form 4/A |
| CASAMENTO CHARLES J Director | 2013-04-22 19:51:09 | 26,125 0 | 26,125 | Form 4 |
| SHORTLIFFE LINDA M DAIRIKI Director | 2013-01-29 21:02:58 | 26,125 0 | 26,125 | Form 4 |
| WILSON ROBERT N Director | 2013-08-16 18:05:06 | 25,000 0 | 25,000 | Form 4 |
| LOGAN MARK B Director | 2013-08-16 18:13:34 | 25,000 0 | 25,000 | Form 4 |
| CARROLL J MARTIN Director | 2013-08-16 18:03:50 | 25,000 0 | 25,000 | Form 4 |
| DENNER ALEXANDER J Director | 2015-11-03 17:13:07 | 25,000 0 | 25,000 | Form 4 |
| JOHANNES JACOB PIETER KASTELEIN Director | 2013-08-16 18:00:51 | 25,000 0 | 25,000 | Form 4 |
| Roberts Eric W Director | 2019-03-04 16:45:39 | 16,660 0 | 16,660 | Form 4 |
| Ferrell Karen E. Director | 2020-02-24 18:05:22 | 15,000 0 | 15,000 | Form 4 |
| KANGAS EDWARD A Director | 2020-02-24 18:05:46 | 15,000 0 | 15,000 | Form 4 |
| KING THOMAS BRAXTON Director | 2020-02-24 18:06:09 | 15,000 0 | 15,000 | Form 4 |
| Norton David Y Director | 2020-02-24 18:06:31 | 15,000 0 | 15,000 | Form 4 |
| Plutzky Jorge MD Director | 2020-02-24 18:06:54 | 15,000 0 | 15,000 | Form 4 |
| ROSENMAN HERM Director | 2020-02-24 18:07:15 | 15,000 0 | 15,000 | Form 4 |
| Shaw Allan Director | 2018-10-29 19:56:31 | 15,000 0 | 15,000 | Form 4 |
| ASTRUE MICHAEL J Director | 2013-09-06 16:09:29 | 10000 0 | 10000 | Form 4 |
| BIRO JON C SEE REMARKS 10% Owner | 2013-07-01 18:21:44 | 4000 0 | 4000 | Form 4 |
| STRAUSS LARRY J Vice President, Finance & CFO | 2004-06-25 10:13:24 | 774 0 | 774 | Form 4 |
| STRACHAN GRAHAM Director | 2010-05-07 20:37:41 | 0 0 | 0 | Form 4 |
| PLACE VIRGIL A Chief Scientific Officer | 2010-05-07 20:35:11 | 0 0 | 0 | Form 4 |
| Changjin Wang VP, Business Development | 2008-12-01 17:13:17 | 0 0 | 0 | Form 4 |
| ROSATI MARIO M Director | 2008-09-09 17:09:01 | 0 0 | 0 | Form 4 |
| DIETRICH JOHN W Vice President, R&D | 2007-05-02 08:46:04 | 0 0 | 0 | Form 4 |
| NIDA TERRY VP, Worldwide Mktg/Corp Dvlop | 2007-01-03 09:46:12 | 0 0 | 0 | Form 4 |
| GESUNDHEIT NEIL Vice President, Clinical | 2005-10-19 15:04:38 | 0 0 | 0 | Form 4 |
| NICKEL JAMES R VP, Clinical Medicine | 2005-02-01 14:47:15 | 0 0 | 0 | Form 4 |
| ZOLTOWSKI CAROL VP, Regulatory Affairs | 2005-02-01 14:44:29 | 0 0 | 0 | Form 4 |